Clinical Trial: A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777133) titled 'A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy Female Participants' on Aug. 18.

Brief Summary: The purpose of this study is to evaluate the metabolism, the routes and extent of elimination, and drug levels of [14C]Navlimetostat (BMS-986504) in healthy female participants

Study Start Date: Sept. 16

Study Type: INTERVENTIONAL

Condition: Healthy Female Participants

Intervention: DRUG: Navlimetostat

Specified dose on specified days

DRUG: [14C]Navlimetostat

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Br...